Main Menu

Publications Highlights View all by category

Types of Publications


Journal Articles

Carreno, G., Boult, J.K., Apps, J., Gonzalez-Meljem, J.M., Haston, S., Guiho, R., Stache, C., Danielson, L.S., Koers, A., Smith, L.M., et al. (2019). SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. Endocrine-related cancer, , pp. 355-366.  show abstract

Burley, T.A., Mączyńska, J., Shah, A., Szopa, W., Harrington, K.J., Boult, J.K., Mrozek-Wilczkiewicz, A., Vinci, M., Bamber, J.C., Kaspera, W., et al. (2018). Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment. International journal of cancer, Vol.142 (11), pp. 2363-2374.

Khan, A.A., Paget, J.T., McLaughlin, M., Kyula, J.N., Wilkinson, M.J., Pencavel, T., Mansfield, D., Roulstone, V., Seth, R., Halle, M., et al. (2018). Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Science translational medicine, Vol.10, pp. eaar2041-eaar2041.  show abstract

Papaevangelou, E., Boult, J.K., Whitley, G.S., Robinson, S.P. & Howe, F.A. (2018). Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo. Angiogenesis, Vol.21 (4), pp. 737-749.

Robinson, S.P., Boult, J.K., Vasudev, N.S. & Reynolds, A.R. (2017). Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI. Cancer research, Vol.77 (15), pp. 4127-4134.

Almeida, G.S., Panek, R., Hallsworth, A., Webber, H., Papaevangelou, E., Boult, J.K., Jamin, Y., Chesler, L. & Robinson, S.P. (2017). Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform. British journal of cancer, Vol.117 (6), pp. 791-800.

Baker, L.C., Boult, J.K., Thomas, M., Koehler, A., Nayak, T., Tessier, J., Ooi, C.-., Birzele, F., Belousov, A., Zajac, M., et al. (2016). Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling. British journal of cancer, Vol.115 (6), pp. 691-702.

Jerome, N.P., Boult, J.K., Orton, M.R., d’Arcy, J., Collins, D.J., Leach, M.O., Koh, D.-. & Robinson, S.P. (2016). Modulation of renal oxygenation and perfusion in rat kidney monitored by quantitative diffusion and blood oxygen level dependent magnetic resonance imaging on a clinical 1 5T platform. Bmc nephrology, Vol.17 (1).

Jamin, Y., Boult, J.K., Li, J., Popov, S., Garteiser, P., Ulloa, J.L., Cummings, C., Box, G., Eccles, S.A., Jones, C., et al. (2015). Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography. Cancer res, Vol.75 (7), pp. 1216-1224.  show abstract

McErlean, C.M., Boult, J.K., Collins, D.J., Leach, M.O., Robinson, S.P. & Doran, S.J. (2015). Detecting microvascular changes in the mouse spleen using optical computed tomography. Microvascular research, Vol.101, pp. 96-102.

Hill, R.M., Kuijper, S., Lindsey, J.C., Petrie, K., Schwalbe, E.C., Barker, K., Boult, J.K., Williamson, D., Ahmad, Z., Hallsworth, A., et al. (2015). Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease. Cancer cell, Vol.27 (1), pp. 72-84.  show abstract

O’Connor, J.P., Boult, J.K., Jamin, Y., Babur, M., Finegan, K.G., Williams, K.J., Little, R.A., Jackson, A., Parker, G.J., Reynolds, A.R., et al. (2015). Oxygen enhanced MRI accurately identifies, quantifies, and maps hypoxia in preclinical cancer models. Cancer research, (in press).

Li, J., Jamin, Y., Boult, J.K., Cummings, C., Waterton, J.C., Ulloa, J., Sinkus, R., Bamber, J.C. & Robinson, S.P. (2014). Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography. Br j cancer, Vol.110 (7), pp. 1727-1732.  show abstract

Lin, G., Hill, D.K., Andrejeva, G., Boult, J.K., Troy, H., Fong, A.-., Orton, M.R., Panek, R., Parkes, H.G., Jafar, M., et al. (2014). Dichloroacetate induces autophagy in colorectal cancer cells and tumours. Br j cancer, Vol.111 (2), pp. 375-385.  show abstract

Baker, L.C., Boult, J.K., Jamin, Y., Gilmour, L.D., Walker-Samuel, S., Burrell, J.S., Ashcroft, M., Howe, F.A., Griffiths, J.R., Raleigh, J.A., et al. (2013). Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenation. Int j radiat oncol biol phys, Vol.87 (1), pp. 160-167.  show abstract

Burrell, J.S., Walker-Samuel, S., Baker, L.C., Boult, J.K., Jamin, Y., Halliday, J., Waterton, J.C. & Robinson, S.P. (2013). Exploring ΔR(2) * and ΔR(1) as imaging biomarkers of tumor oxygenation. J magn reson imaging, Vol.38 (2), pp. 429-434.  show abstract

Boult, J.K., Terkelsen, J., Walker-Samuel, S., Bradley, D.P. & Robinson, S.P. (2013). A multi-parametric imaging investigation of the response of C6 glioma xenografts to MLN0518 (tandutinib) treatment. Plos one, Vol.8 (4), p. e63024.  show abstract

Hill, D.K., Orton, M.R., Mariotti, E., Boult, J.K., Panek, R., Jafar, M., Parkes, H.G., Jamin, Y., Miniotis, M.F., Al-Saffar, N.M., et al. (2013). Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data. Plos one, Vol.8 (9), p. e71996.  show abstract

Boult, J.K., Jamin, Y., Jacobs, V., Gilmour, L.D., Walker-Samuel, S., Halliday, J., Elvin, P., Ryan, A.J., Waterton, J.C. & Robinson, S.P., et al. (2012). False-negative MRI biomarkers of tumour response to targeted cancer therapeutics. Br j cancer, Vol.106 (12), pp. 1960-1966.  show abstract

Baker, L.C., Boult, J.K., Walker-Samuel, S., Chung, Y.-., Jamin, Y., Ashcroft, M. & Robinson, S.P. (2012). The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function. Br j cancer, Vol.106 (10), pp. 1638-1647.  show abstract

Burrell, J.S., Bradley, R.S., Walker-Samuel, S., Jamin, Y., Baker, L.C., Boult, J.K., Withers, P.J., Halliday, J., Waterton, J.C. & Robinson, S.P., et al. (2012). MRI measurements of vessel calibre in tumour xenografts: comparison with vascular corrosion casting. Microvasc res, Vol.84 (3), pp. 323-329.  show abstract

Walker-Samuel, S., Boult, J.K., McPhail, L.D., Box, G., Eccles, S.A. & Robinson, S.P. (2012). Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts. Int j cancer, Vol.130 (6), pp. 1284-1293.  show abstract

Burrell, J.S., Walker-Samuel, S., Baker, L.C., Boult, J.K., Jamin, Y., Ryan, A.J., Waterton, J.C., Halliday, J. & Robinson, S.P. (2012). Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas. Int j cancer, Vol.131 (8), pp. 1854-1862.  show abstract

Walker-Samuel, S., Orton, M., Boult, J.K. & Robinson, S.P. (2011). Improving apparent diffusion coefficient estimates and elucidating tumor heterogeneity using Bayesian adaptive smoothing. Magn reson med, Vol.65 (2), pp. 438-447.  show abstract

Kostourou, V., Cartwright, J.E., Johnstone, A.P., Boult, J.K., Cullis, E.R., Whitley, G.S. & Robinson, S.P. (2011). The role of tumour-derived iNOS in tumour progression and angiogenesis. Brit j cancer, Vol.104 (1), pp. 83-90.  show abstract

Burrell, J.S., Walker-Samuel, S., Baker, L.C., Boult, J.K., Ryan, A.J., Waterton, J.C., Halliday, J. & Robinson, S.P. (2011). Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging. Magn reson med, Vol.66 (1), pp. 227-234.  show abstract

Boult, J.K., Walker-Samuel, S., Jamin, Y., Leiper, J.M., Whitley, G.S. & Robinson, S.P. (2011). Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. J pathol, Vol.225 (3), pp. 344-352.  show abstract

Ratté, S., Vreugdenhil, M., Boult, J.K., Patel, A., Asante, E.A., Collinge, J. & Jefferys, J.G. (2011). Threshold for epileptiform activity is elevated in prion knockout mice. Neuroscience, Vol.179, pp. 56-61.  show abstract

Walker-Samuel, S., Orton, M., McPhail, L.D., Boult, J.K., Box, G., Eccles, S.A. & Robinson, S.P. (2010). Bayesian estimation of changes in transverse relaxation rates. Magn reson med, Vol.64 (3), pp. 914-921.  show abstract

Walker-Samuel, S., Orton, M., Boult, J.K. & Robinson, S.P. (2010). Improving apparent diffusion coefficient estimates and elucidating tumor heterogeneity using Bayesian adaptive smoothing. Magn reson med, .  show abstract

Akagi, T., Ito, T., Kato, M., Jin, Z., Cheng, Y., Kan, T., Yamamoto, G., Olaru, A., Kawamata, N., Boult, J., et al. (2009). Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma. Int j cancer, Vol.125 (10), pp. 2349-2359.  show abstract

Brookes, M.J., Boult, J., Roberts, K., Cooper, B.T., Hotchin, N.A., Matthews, G., Iqbal, T. & Tselepis, C. (2008). A role for iron in Wnt signalling. Oncogene, Vol.27 (7), pp. 966-975.  show abstract

Boult, J., Roberts, K., Brookes, M.J., Hughes, S., Bury, J.P., Cross, S.S., Anderson, G.J., Spychal, R., Iqbal, T. & Tselepis, C., et al. (2008). Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma. Clin cancer res, Vol.14 (2), pp. 379-387.  show abstract

Boult, J.K., Tanière, P., Hallissey, M.T., Campbell, M.J. & Tselepis, C. (2008). Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network. Br j cancer, Vol.98 (12), pp. 1985-1992.  show abstract

Jamin, Y., Tucker, E.R., Poon, E.S., Popov, S., Vaughan, L., Boult, J.K., Webber, H., Hallsworth, A., Baker, L.C., Jones, C., et al. Evaluation of clinically translatable magnetic resonance imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma. Radiology, .

Robinson, S., Boult, J., Baker, L. & Jamin, Y. Investigating the Vascular Phenotype of Subcutaneously and Orthotopically Propagated PC3 Prostate Cancer Xenografts Using Combined Carbogen USPIO (CUSPIO) MRI. Topics in magnetic resonance imaging, .

Boult, J., Popov, S., Box, G., Eccles, S., Jones, C. & Robinson, S. Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd- DTPA and USPIO-enhanced imaging. Nmr in biomedicine, .

Boult, J.K., Danielson, L.S., Smith, L.M., Koers, A., Chesler, L. & Robinson, S.P. PRECLINICAL TRANSGENIC AND PATIENT-DERIVED XENOGRAFT MODELS RECAPITULATE THE RADIOLOGICAL FEATURES OF HUMAN ADAMANTINOMATOUS CRANIOPHARYNGIOMA. Brain pathology, .

Boult, J., Box, G., Vinci, M., Perryman, L., Eccles, S., Jones, C. & Robinson, S. Evaluation of the response of intracranial xenografts to VEGF signaling inhibition using multiparametric MRI. Neoplasia, .

Jerome, N., Boult, J., Orton, M., d'Arcy, J.A., Nerurkar, A., Leach, M., Koh, D., Collins, D.J. & Robinson, S. Characterisation of fibrosis in chemically-induced rat mammary carcinomas using multi-modal endogenous contrast MRI on a 1 5T clinical platform. European radiology, .

Little, R.A., Jamin, Y., Boult, J.K., Naish, J.H., Watson, Y., Cheung, S., Holliday, K.F., Lu, H., McHugh, D.J., Irlam, J., et al. Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI: Comparison with Intrinsic Susceptibility MRI and Pathology. Radiology, Vol.288 (3), pp. 739-747.  show abstract

Baker, L.C., Sikka, A., Price, J.M., Boult, J.K., Lepicard, E.Y., Box, G., Jamin, Y., Spinks, T.J., Kramer-Marek, G., Leach, M.O., et al. Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma. Frontiers in oncology, Vol.8.

Al-Saffar, N., Wong Te Fong, A., Gowan, S., Boult, J., Robinson, S., Eccles, S., Yap, T., Leach, M., Paravati, R. & Chung, Y., et al. Metabolic biomarkers for the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma. British journal of cancer, .

Li, J., Zormpas-Petridis, K., Boult, J., Reeves, E., Chesler, L., Jones, C., Bamber, J., Yuan, Y., Jamin, Y. & Robinson, S., et al. Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Non-invasive Magnetic Resonance Elastography. Cancer research, .


Conferences

Izquierdo, E., Carvalho, D., Boult, J., Mackay, A., Temelso, S., Molinari, V., Stubbs, M., Burke, R., Depani, S., O’Hare, P., et al. (2019). DIPG-25. GENETIC ALTERATIONS TARGETING THE MAPK PATHWAY CONFERS PRECLINICAL SENSITIVITY TO TRAMETINIB IN A CO-CLINICAL TRIAL IN DIPG, Neuro-Oncology, Vol.21 (Supplement_2), p.ii74.

Apps, J., Carreno, G., Boult, J., Gutteridge, A., Danielson, L., Jani, N., Tossell, K., Forshew, T., Hargrave, D., Chesler, L., et al. (2017). Molecular profiling and preclinical targeted therapeutic testing in adamantinomatous craniopharyngioma, LANCET, Vol.389, p.22.

Fofana, M., Boult, J.K., Vinci, M., Molinari, V., Popov, S., Mackay, A., Carcaboso, A.M., Jones, C. & Robinson, S.P. (2016). IN VIVO MAGNETIC RESONANCE IMAGING IDENTIFIES CLINICAL PHENOTYPES OF PAEDIATRIC GLIOBLASTOMA IN AN ORTHOTOPIC MOUSE XENOGRAFT MODEL, NEURO-ONCOLOGY, Vol.18, pp.140-141.

Boult, J., Apps, J., Hutchinson, C., Carreno, G., Danielson, L., Smith, L., Koers, A., Arthurs, O., Chesler, L., Martinez-Barbera, J.-., et al. (2016). A GENETICALLY ENGINEERED MOUSE MODEL RECAPITULATES RADIOLOGICAL FEATURES OF HUMAN ADAMANTINOMATOUS CRANIOPHARYNGIOMA, Presented at International Symposium on Pediatric Neuro-Oncology, NEURO-ONCOLOGY, Vol.18, p.139.

Li, J., Boult, J.K., Vinci, M., Popov, S., Barker, K., Ahmad, Z., Jamin, Y., Cummings, C., Eccles, S.A., Bamber, J.C., et al. (2015). Abstract 1488:In vivomagnetic resonance elastography in pediatric brain tumor models, Presented at Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA, Tumor Biology, .

Boult, J.K., Taylor, K.R., Vinci, M., Popov, S., Jury, A., Molinari, V., Alonso, M.M., Ingram, W., Caraboso, A.M., Monje, M., et al. (2015). Abstract 3271: Novel orthotopic pediatric high grade glioma xenografts evaluated with magnetic resonance imaging mimic human disease, Presented at Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA, Tumor Biology, .

Hill, R.M., Kuijper, S., Lindsey, J., Schwalbe, E.C., Barker, K., Boult, J., Williamson, D., Ahmad, Z., Hallsworth, A., Ryan, S., et al. (2014). Abstract LB-201: MYC and TP53 defects interact at medulloblastoma relapse to define rapidly progressive disease and can be targeted therapeutically, Presented at Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA, Tumor Biology, .

Boult, J., Vinci, M., Taylor, K., Perryman, L., Box, G., Jury, A., Popov, S., Ingram, W., Monje, M., Eccles, S., et al. (2014). NOVEL ORTHOTOPIC PAEDIATRIC GLIOBLASTOMA XENOGRAFTS EVALUATED WITH MAGNETIC RESONANCE IMAGING MIMIC HUMAN DISEASE, NEURO-ONCOLOGY, Vol.16, p.48.

Boult, J., Li, J., Vinci, M., Jury, A., Popov, S., Jamin, Y., Cummings, C., Eccles, S., Bamber, J., Sinkus, R., et al. (2014). IMAGING THE TENSIONAL HOMEOSTASIS OF ORTHOTOPIC PAEDIATRIC GLIOMA XENOGRAFTS IN VIVO WITH MAGNETIC RESONANCE ELASTOGRAPHY, NEURO-ONCOLOGY, Vol.16, pp.48-49.

Hill, R., Kuijper, S., Lindsey, J., Schwalbe, E., Barker, K., Boult, J., Williamson, D., Ahmad, Z., Hallsworth, A., Ryan, S., et al. (2014). MYC AND TP53 DEFECTS EMERGE AND INTERACT AT MEDULLOBLASTOMA RELAPSE, DEFINE RAPIDLY PROGRESSIVE DISEASE AND CAN BE TARGETED THERAPEUTICALLY, NEURO-ONCOLOGY, Vol.16, p.74.

Price, J.M., Baker, L.C., Boult, J.K., Box, C., Kramer-Marek, G., Murray, I., Robinson, S.P. & Leach, M.O. (2014). 18F-fluorodeoxyglucose (FDG) uptake is increased in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistant compared with sensitive head and neck cancer xenografts, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, Vol.41, p.S638.

Boult, J.K., Jury, A., Popov, S., Perryman, L., Box, G., Jones, C., Eccles, S.A. & Robinson, S.P. (2013). Abstract 1559: Evaluation of MR imaging biomarkers of the vascular and infiltrative phenotype in intracranial MDA-MB-231 tumors., Presented at Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC, Tumor Biology, .

Baker, L.C., Chung, Y.-., Boult, J.K., Ashcroft, M.A. & Robinson, S.P. (2011). The effects of the HIF pathway inhibitor NSC-134754 on glucose metabolism, CANCER RESEARCH, Vol.71.

Jamin, Y., Cullis, E.R., Vaughan, L., Webber, H., Boult, J.K., Baker, L.C., Dow-Mu, K., Chesler, L. & Robinson, S.P. (2011). Abstract 5290: Imaging biomarkers of response to chemotherapy in neuroblastoma, Presented at Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL, Tumor Biology, .

Baker, L.C., Chung, Y.-., Boult, J.K., Ashcroft, M.A. & Robinson, S.P. (2011). Abstract 4074: The effects of the HIF pathway inhibitor NSC-134754 on glucose metabolism, Presented at Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL, Cellular and Molecular Biology, .

Perryman, L.A., Box, G., Boult, J.K., Marshall, L., Popoy, S., Jury, A., Pearson, A.D., Workman, P., Hargrave, D., Robinson, S., et al. (2010). DEVELOPMENT AND CHARACTERISATION OF IN VIVO MODELS OF PAEDIATRIC HIGH-GRADE GLIOMA, Presented at 14th International Symposium on Pediatric Neuro-Oncology, Vienna, AUSTRIA. NEURO-ONCOLOGY, Vol.12 (6), pp.II49-II50.

Boult, J., Walker-Samuel, S., Leiper, J., Whitley, G. & Robinson, S. (2009). Effect of active site mutant DDAH1 in C6 glioma xenografts, CANCER RESEARCH, Vol.69.

Walker-Samuel, S., Boult, J., McPhail, L., Box, G., Eccles, S. & Robinson, S. (2009). Non-invasive assessment of tumor vessel size in orthotopic prostate tumors and response to the vascular disrupting agent ZD6126, CANCER RESEARCH, Vol.69.

Boult, J.K., Robinson, S.P., Walker-Samuel, S. & Bradley, D.P. (2009). CHRONIC DOSING WITH MLN0518 (TANDUTINIB), A SMALL MOLECULE PDGFR ALPHA/BETA INHIBITOR, REDUCES TUMOR HYPOXIA AND PERFUSION IN C6 GLIOMA XENOGRAFTS, NEURO-ONCOLOGY, Vol.11 (5), p.588.

Boult, J.K., Walker‐Samuel, S., Bradley, D.P. & Robinson, S.P. (2009). Abstract B257: Chronic dosing with MLN0518 (Tandutinib), a small molecule PDGFRα/β inhibitor, reduces tumor growth, hypoxia, and perfusion in C6 glioma xenografts: An investigation using immunohistochemical and MRI methods, Presented at Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA, Therapeutic Agents - Small Molecule Kinase Inhibitors, .

Baker, L.C., Boult, J.K., Walker‐Samuel, S., Jamin, Y., Ashcroft, M.A. & Robinson, S.P. (2009). Abstract C90: An MRI and histological investigation of the acute response of orthotopic PC3 prostate tumors to the HIF pathway inhibitor NSC‐134754in vivo, Presented at Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA, Other Therapeutic Agents, .

Roberts, K., Boult, J., Brookes, M., Iqbal, T., Spychal, R. & Tselepis, C. (2008). Deregulated iron metabolism in oesophageal carcinogenesis, ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, Vol.90 (4), p.353.

Roberts, K., Brookes, M.J., Boult, J., Mckie, A.T., Iqbal, T., Spychal, R. & Tselepis, C. (2007). Expression of Hcp-1 in oesophageal carcinogenesis, GASTROENTEROLOGY, Vol.132 (4), p.A305.

Roberts, K., Brookes, M.J., Boult, J., Anderson, G.J., Spychal, R., Iqbal, T. & Tselepis, C. (2007). A modulation of iron transport proteins in oeosphageal adenocarcinoma, GASTROENTEROLOGY, Vol.132 (4), p.A303.

Brookes, M., Boult, J., Iqbal, T. & Tselepis, C. (2007). A role for iron in Wnt signalling and human colorectal carcinogenesis, AMERICAN JOURNAL OF HEMATOLOGY, Vol.82 (6), p.560.

Tselepis, C., Brookes, M., Boult, J., Roberts, K., Anderson, G., Spychal, B. & Iqbal, T. (2007). A modulation of iron transport proteins in oesophageal adenocarcinoma, AMERICAN JOURNAL OF HEMATOLOGY, Vol.82 (6), p.527.

Iqbal, T., Brookes, M., Roberts, K., Boult, J., McKie, A., Spychal, B. & Tselepis, C. (2007). Expression of HCP-1 in oesophageal carcinogenesis, AMERICAN JOURNAL OF HEMATOLOGY, Vol.82 (6), pp.527-528.

Brookes, M.J., Boult, J., Hughes, S., Sharma, N., Ismail, T., Hamilton, E., Iqbal, T. & Tselepis, C. (2006). A role for iron transporters in colorectal adenocarcinoma, GUT, Vol.55, p.A89.

Boult, J., Hughes, S., Brookes, M.J., Roberts, K., Taniere, P., Iqbal, T. & Tselepis, C. (2006). A role for iron transporters in oesophageal adenocarcinoma, GUT, Vol.55, p.A88.

Brookes, M.J., Hughes, S., Boult, J., Sharma, N., Turner, F., Ismail, T., Iqbal, T. & Tselepis, C. (2006). Colonic iron loading reduces E-cadherin expression and enhances proliferation, GUT, Vol.55, p.A87.

Boult, J., Taniere, P., Campbell, M. & Tselepis, C. (2006). Regulation of the Myc network in the progression to esophageal adenocarcinoma, CANCER RESEARCH, Vol.66 (8).

Boult, J.K., Bury, J.P., Bullock, A.J., Campbell, M.J., Taniere, P., MacNeil, S. & Tselepis, C. (2005). Regulation of the MYC network in the progression to oesophageal adenocarcinoma, GUT, Vol.54, p.A87.

Boult, J., Young, L.S., Campbell, M.J. & Tselepis, C. (2004). Cytokine mediated modulation of the myc network in Barrett's metaplasia, BRITISH JOURNAL OF CANCER, Vol.91, p.S66.

In this section

Publications